Briefly, this study uncovers a brand new insight into the impact of TME on T cell metabolic reprogramming, which innovatively illustrates the relationship between pyruvate shunt metabolism and CD8+ T cell function from the perspective of metabolic microenvironment, and provides the therapeutic potential of targeting T cell metabolism to strengthen cytotoxicity in tumor immunotherapy. The gene discussed is CD8A; the disease is neoplasm.